Topical amphotericin B and subconjunctival injection of fluconazole (Combination Therapy) versus topical amphotericin B (Monotherapy) in treatment of keratomycosis

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 3, 2010, Pages 281-285

  Mahdy, Reda A ^a   Nada, Waleed M ^a   Wageh, Mostafa M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ATROPINE; FLUCONAZOLE; GATIFLOXACIN; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGAR MEDIUM; AGED; ARTICLE; CANDIDA; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA NECROSIS; CONJUNCTIVAL HEMORRHAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; CORNEA PERFORATION; CORNEA ULCER; CULTURE MEDIUM; ENDOPHTHALMITIS; FEMALE; FUNGUS SPORE; GRAM STAINING; HUMAN; KERATOMYCOSIS; LABORATORY TEST; MALE; MICROSCOPY; NECROSIS; PENETRATING KERATOPLASTY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SMEAR; TREATMENT DURATION; COMPARATIVE STUDY; CONJUNCTIVA; DRUG COMBINATION; EYE INFECTIONS, FUNGAL; FOLLOW UP; FUNGUS; INJECTION; ISOLATION AND PURIFICATION; KERATITIS; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; TOPICAL DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CONJUNCTIVA; DRUG THERAPY, COMBINATION; EYE INFECTIONS, FUNGAL; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; FUNGI; HUMANS; INJECTIONS; KERATITIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77954204590     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0005     Document Type: Article

References (20)

1. Jurkunas, U., Behlau, I., and Colby, K. Fungal keratitis: changing pathogens and risk factors. Cornea 28:638-643, 2009.
2. AL-Hussaini, A.K., El-Shanawany, A., Daef, E.A., and Abdel Latif, M.M. Topical clotrimazole versus topical micronazole in the treatment of experimental keratomycosis. Bull. Ophthalmol. Soc. Egypt 90:809-812, 1997.
3. Morand, K., Bartoletti, A.C., Bochot, A., Barratt, G., Brandely, M.L., and Chast, F. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Int. J. Pharm. 344:150-153, 2007.
4. Qu, L., Li, L., and Xie, H. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model. Ophthalmic Res. 43:153- 158, 2010.
5. O'Brien, T.P. Therapy of ocular fungal infections. In: Karen Whitaker Sorensen, eds. Ocular Infections: Update On Therapy, Ophthalmology Clinics of North America. Vol.12. Canada: Elsevier, Inc.; 1999; pp. 33-41.
6. Yilmaz, S., and Maden, A. Severe fungal keratitis treated with subconjunctival fluconazole. Am. J. Ophthalmol. 140:454-458, 2005.
7. Isipradit, S. Efficacy of fluconazole subconjunctival injection as adjunctive therapy for severe recalcitrant fungal corneal ulcer. J. Med. Assoc. Thai. 91:309-315, 2008.
8. Prakash, G., Sharma, N., Goel, M., Titiyal, J.S., and Vajpayee, R.B. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am. J. Ophthalmol. 146:56-59, 2008.
9. Shi, W., Wang, T., Xie, L., Li, S., Gao, H., Liu, J., and Li, H. Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation. Ophthalmology. 117:890-896, 2010.
10. Rondeau, N., Bourciew, T., Chaumeil, C., Borderie, V., Touzeau, O., Seat, Y., Thomas, F., Baudouni, C., Nordmann, J., and Larache, L. Fungal keratitis at the Centre Hospitalier National: retrospective study of 19 cases. J. Fr. Ophtalmol. (25)9:890-896, 2002.
11. Dupuis, A., Tournier, N., Le Moal, G., and Venisse, N. Preparation and stability of voriconazole eye drop solution. Antimicrob. Agents Chemother. 53:798-799, 2009.
12. El-Gohary, M.A., El-Desoky, E., and El-Shorbagy, M.S. Clinical versus laboratory diagnosis of mycotic keratitis. Bull. Ophthalmol. Soc. Egypt (92), 6:1121-1123, 1999.
13. Leibowitz, H.M. Fungal keratitis. In: Leibowitz, H.M. ed. Corneal Disorders. Clinical Diagnosis and Management. UK: WB Saunders Company; 1984; pp. 424-430.
14. Garg, P., Gopinathan, U., Choudhary, K., and Rao, G.N. Keratomycosis, clinical and microbiological experience with dematiaceous fungi. Ophthalmology 107:576-580, 2000.
15. Sharma, S., Kunimoto, D.Y., Gopinathan, U., Athmanathan, S., and Garg, P.R. Evaluation of corneal scrapping smear examination method in diagnosis of bacterial and fungal keratitis: a survey of 18 years of laboratory experience. Cornea (21) 7:643-647, 2002.
16. Gopinathan, U., Garg, P., Fernandez, M., Shama, S., and Athmanathan, S. Epidemiological features and laboratory results of fungal keratitis: a 10 years review at a Referal Eye Care Center in South India. Cornea 21 (6):355-358, 2002.
17. Nayak, N. Fungal infection of the eye, laboratory diagnosis and treatment. Nepal Med. Coll. J. Mach. 10:48-63, 2008.
18. Al-Hussaini, M.K., Abdel Kader, M.I., Massoud, A., Abu Ghadeer, A., and Al-Hussaini, A.K. Diagnosis and therapy with ketoconazole. Bull. Ophthalmol. Soc. Egypt (8):113-115, 1988.
19. Ritter, J.M., Lewis, L.D., and Mant, T.G. Fungal infection. In: Lewis, L.D., Ritter, J.M., and Mant, T.G., eds. Textbook of Clinical Pharmacology. 4th ed. New York: Oxford University Press Inc.; 1999; pp. 504-508.
20. Avunduk, A.M., Warnel, E.D., Kaufman, H.E., and Greer, D. Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis. Curr. Eye Res. 26:113-117, 2003.